We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 45% below its sector, cheaper than its peers on earnings.
Headquartered in Altstätten, Switzerland, COLTENE Holding AG, established in 2005 and formerly known as Medisize Holding AG until its name change in April 2008, is a global leader in the development, manufacturing, and sale of a diverse range of consumables, instruments, and equipment specifically designed for dentists and dental laboratories. The company's comprehensive product line addresses various aspects of dental care across Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. Key offerings include advanced materials for restorations, such as conventional and bulk-fill composites, CAD/CAM solutions, bonding agents, and curing lights. For endodontic procedures, they provide specialized tools like rotary and hand files, irrigation solutions, and obturation materials. Their prosthetics segment features products for bite registration and impression materials like A-silicones and C-silicones. Additionally, COLTENE supplies essential treatment auxiliaries, including dental rolls, aspirator tips, and dental dams; infection control solutions such as ultrasonic cleaning units and patient bibs; and a variety of rotary instruments, including diamond and carbide burs. The company also offers a full suite of laboratory products, encompassing gingiva masks, model making materials, and specialized burs and polishers.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save CLTN.SW and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
